impact factor, citescore
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER13036Rapid and sustained improvements in patient-reported signs and symptoms with ixekizumab in biologic-naive and TNF-inadequate responder patients with psoriatic arthritis20.00 €
 Subtotal 20.00 €